#
Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hy
  • Professionals
  • FDA PI

Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide Elixir

Dosage form: oral elixir
Drug class:Anticholinergics / antispasmodics

Medically reviewed by Drugs.com. Last updated on Aug 1, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. Read further information about unapproved drugs.

Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide Elixir Description

Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide Elixir - Grape
Each 5 mL (teaspoonful) of elixir (alcohol not more than 23.8%) contains:
Phenobarbital, USP..... 16.2 mg
Hyoscyamine Sulfate, USP..... 0.1037 mg
Atropine Sulfate, USP..... 0.0194 mg
Scopolamine Hydrobromide, USP.... 0.0065 mg

Inactive Ingredients
Purified Water, Glycerin, Sorbitol, Ethyl Alcohol, Sucrose, Saccharin Sodium, Artificial and Natural Grape Flavor, FD&C Red #3, and FD&C Blue #1.

Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide Elixir – Mint
Each 5 mL (teaspoonful) of elixir (alcohol not more than 23.8%) contains:
Phenobarbital, USP..... 16.2 mg
Hyoscyamine Sulfate, USP..... 0.1037 mg
Atropine Sulfate, USP..... 0.0194 mg
Scopolamine Hydrobromide, USP.... 0.0065 mg

Inactive Ingredients
Purified Water, Glycerin, Sorbitol, Ethyl Alcohol, Sucrose, Saccharin Sodium, Natural Mint Flavor, FD&C Yellow #5, and FD&C Blue #1.

Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide Elixir - Clinical Pharmacology

This drug combination provides natural belladonna alkaloids in a specific, fixed ratio combined with phenobarbital to provide peripheral anticholinergic/antispasmodic action and mild sedation.

INDICATIONS AND USAGE
Based on a review of this drug by the National Academy of Sciences-National Research Council and/or other information, FDA has classified the indications as follows: